Bladder Cancer Cohort Analysis

AS Avinash Sahu
XW Xiaoman Wang
PM Phillip Munson
JK Jan P.G. Klomp
XW Xiaoqing Wang
SG Shengqing Stan Gu
YH Ya Han
GQ Gege Qian
PN Phillip Nicol
ZZ Zexian Zeng
CW Chenfei Wang
CT Collin Tokheim
WZ Wubing Zhang
JF Jingxin Fu
JW Jin Wang
NN Nishanth Ulhas Nair
JR Joost A.P. Rens
MB Meriem Bourajjaj
BJ Bas Jansen
IL Inge Leenders
JL Jaap Lemmers
MM Mark Musters
SZ Sanne van Zanten
LZ Laura van Zelst
JW Jenny Worthington
JL Jun S. Liu
DJ Dejan Juric
CM Clifford A. Meyer
AO Arthur Oubrie
XL X. Shirley Liu
DF David E. Fisher
KF Keith T. Flaherty
ask Ask a question
Favorite

The RNA-seq data and clinical annotation were collected from the bladder cancer patient cohort (139). Patients were clustered using cytokine expressions (genes in KEGG_CYTOKINE_CYTOKINE_INTERACTIONS pathway) by uniform manifold approximation and projection (UMAP) dimension reduction using “uwot” with parameters n_neighbors = 40; learning_rate = 0.1; min_dist = 0.001; number of PC = 10. The clustering resulted in two clusters. DEGs between two clusters were identified by the R package “Seurat.” Finally, ESRRA activities were compared among UMAP clusters, immune phenotypes, and Lund2 classification of bladder cancer (140). The significance of comparisons was determined using the Wilcoxon test for pairwise comparison and the Kruskal–Wallis test for group-wise comparison.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A